Pharma News

pharma courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • In-Cosmetics, Global held in Amsterdam, Nederlands
    25 April 2025

    In-Cosmetics, Global held in Amsterdam, Nederlands

    In-Cosmetics Global, the world’s largest conference and exhibition for the cosmetics industry took place from 8th to 10th April 2025 in Amsterdam at RAI Exhibition Center. In-Cosmetics Global is truly, well, global as the event had most of the world’s top personal care ingredient suppliers as well as niche companies making waves in the industry.

    Attendees were from all over the world. Europe accounted to almost 60% of attendees, followed by Asia Pacific, South Central America, and North America and Middle East & Africa.

  • 23 April 2025
    Human Mixtard penfill to be replaced with injectables, Novo Nordisk clarifies
    Novo Nordisk is now discontinuing its Human Mixtard penfill by the year's end. However Mixtard in India will continue to be available in vials. Along with it, other forms of insulin including human insulin from Novo Nordisk will continue to be available in vials & devices for patients across India.
  • 23 April 2025
    Aclaris Therapeutics Secures U.S. Food and Drug Administration IND Clearance for ATI-052
    Aclaris Therapeutics, Inc, a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for a Phase 1a/1b clinical trial of ATI-052, a potential best-in-class bispecific anti-TSLP/IL-4R monoclonal antibody.
  • 23 April 2025
    A repurposed anti-inflammatory drug may help treat alcohol use disorder and related pain

    A preclinical study from scientists at Scripps Research finds that a drug already FDA-approved for treating inflammatory conditions may help reduce both alcohol intake and pain sensitivity two issues that commonly co-occur with alcohol use disorder (AUD).

  • 23 April 2025
    Empowering antibodies to better activate the immune system
    Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these immune proteins can do more than that: They also activate other components of the immune system, which then go to work to clear an infection. A new study from Scripps Research explores the factors that influence how effectively antibodies engage specific immune cells.
  • 22 April 2025
    16 years old team of young researchers developed salt-powered mini fridge for vaccine transport and storage

    Team of Young researchers, still in Indian school, developed a portable, electricity-free refrigeration unit using a salt solution to keep vaccines and other temperature-sensitive materials cool. Team consisting of Dhruv Chaudhary, Mithran Ladhania, and Mridul Jain, is known for their work on Thermavault, a device designed to transport vaccines, medicines, and even transplant organs.

  • 22 April 2025
    Novo Nordisk to stop selling its top insulin brand from India
    Novo Nordisk to stop selling its top brand Human Mixtard from India which is country's top selling insulin alone Rs. 800 Crore. Human Mixtard comes under DPCO and the company is reported to come up with new products in India.
  • 21 April 2025
    Key Enzyme in Lipid Metabolism Linked to Immune System Aging

    Our immune systems weaken as we get older, making fewer cells that fight infection and help us recover from illness and injury. Scientists aren’t completely sure why. They may have a better idea now, however, thanks to a new study in GeroScience.

  • 21 April 2025
    Integrative approach reveals promising candidates for AD risk factors or targets for treatments

    A study published in the American Journal of Human Genetics by researchers at Baylor College of Medicine and the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Children’s Hospital provides solutions to the pressing need to identify factors that influence Alzheimer’s disease (AD) risk or resistance while providing an avenue to explore potential biological markers and therapeutic targets.

  • 18 April 2025
    Lupin Receives EIR from US FDA for its Injectable Facility in Nagpur
    Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients.
Subscribe to Pharma News